BioCentury
ARTICLE | Company News

SQI Diagnostics deal

March 31, 2014 7:00 AM UTC

SQI expanded its deal to develop a custom multiplex test for a drug from an undisclosed pharma. Under the expansion, SQI will develop a 21-plex protein microarray for identifying immunogenic regions w...